Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics

Author:

Jering Karola S.1,Claggett Brian1,Pfeffer Marc A.1,Granger Christopher2,Køber Lars3,Lewis Eldrin F.4,Maggioni Aldo P.5,Mann Douglas6,McMurray John J.V.7,Rouleau Jean‐Lucien8,Solomon Scott D.1,Steg Philippe G.9,Meer Peter10,Wernsing Margaret11,Carter Katherine11,Guo Weinong11,Zhou Yinong11,Lefkowitz Martin11,Gong Jianjian11,Wang Yi11,Merkely Bela12,Macin Stella M.13,Shah Urmil14,Nicolau Jose C.15,Braunwald Eugene16

Affiliation:

1. Cardiovascular Division Brigham and Women's Hospital, and Harvard Medical School Boston MA USA

2. Duke University Medical Center Durham NC USA

3. Rigshospitalet Copenhagen Denmark

4. Division of Cardiovascular Medicine Stanford University School of Medicine, Stanford University Palo Alto CA USA

5. ANMCO Research Center Florence Italy

6. Washington University Medical Center St Louis MO USA

7. British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK

8. Montreal Heart Institute University of Montreal Montreal Canada

9. Université de Paris, AP‐HP (Assistance Publique‐Hôpitaux de Paris), FACT (French Alliance for Cardiovascular Trials) and INSERM U‐1148 Paris France

10. Department of Cardiology University Medical Center Groningen, University of Groningen Groningen The Netherlands

11. Novartis Pharmaceutical Corporation East Hanover NJ USA

12. Semmelweis University, Heart and Vascular Center Budapest Hungary

13. Instituto de Cardiología JF Cabral Corrientes Corrientes Argentina

14. Care Institute of Medical Sciences Ahmedabad India

15. Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo Sao Paulo Brazil

16. TIMI Study Group, Cardiovascular Division Brigham and Women's Hospital, and Harvard Medical School Boston MA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3